Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

A Review of Progress of Immunotherapy Drugs for Hodgkin’s Lymphoma

PharmaSources/YefenghongJuly 03, 2019

Tag: monoclonal antibody , Hengrui , Anti-PD-1 , Hodgkin’s Lymphoma

PharmaSources Customer Service